InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Tyra Biosciences, Inc.

TYRA Clue Score32
United States Fiscal year ends December CIK 0001863127 Results filed 4 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Rehan Verjee
9 Sep 2026
Director
Buy
972
$20.58
$20.00K
Ra Capital Management, L.p.
16 Jun 2025
Director
Buy indirect
11,813
$10.13
$119.67K
Ra Capital Management, L.p.
13 Jun 2025
Director
Buy indirect
120,167
$10.20
$1.23M
Ra Capital Management, L.p.
12 Jun 2025
Director
Buy indirect
31,307
$10.20
$319.33K
Ra Capital Management, L.p.
9 Jun 2025
Director
Buy indirect
186,850
$10.19
$1.90M
Ra Capital Management, L.p.
5 Jun 2025
Director
Buy indirect
213,334
$10.04
$2.14M
Ra Capital Management, L.p.
4 Jun 2025
Director
Buy indirect
997,864
$9.63
$9.61M
Ra Capital Management, L.p.
8 Nov 2024
Director
Buy indirect
1,220,681
$16.25
$19.84M
Alan Fuhrman
30 Oct 2024
Chief Financial Officer
Buy
9,500
$16.00
$151.95K
Boxer Capital, LLC
17 Dec 2021
10% owner
Buy
125,000
$13.12
$1.64M
Ra Capital Management, L.p.
17 Sep 2021
Director
Buy indirect
1,250,000
$16.00
$20.00M
Boxer Capital, LLC
17 Sep 2021
10% owner
Buy
625,000
$16.00
$10.00M
Alta Partners NextGen Fund II Management, LLC
17 Sep 2021
10% owner
Buy indirect
156,250
$16.00
$2.50M
Robert J More
17 Sep 2021
Director
Buy indirect
156,250
$16.00
$2.50M
Cormorant Asset Management, LP
17 Sep 2021
Former 10% Owner
Buy indirect
312,500
$16.00
$5.00M
Show all 150 transactions →

What was left out

Form 4 filings counted 171
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 20
Sales on a Rule 10b5-1 plan 58
Sales straight out of an exercise 43
Sales at will 33
Transactions with no price 0
Shares from compensation/vesting 36,213,077
Sales filed before the plan box existed 2
History held since 17 Sep 2021